Trials / Conditions / ctDNA Monitoring
ctDNA Monitoring
4 registered clinical trials studyying ctDNA Monitoring — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment NCT07366112 | Peking University People's Hospital | Phase 2 |
| Not Yet Recruiting | Abemaciclib for Molecular Residual Disease Detected by Circulating Tumor DNA in HR+/HER2- Early Breast Cancer NCT07292207 | Nagoya City University | Phase 2 |
| Recruiting | ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cance NCT06970912 | Peking University People's Hospital | Phase 2 |
| Unknown | Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention NCT05635630 | Fudan University | N/A |